Alnylam Pharmaceuticals | DŁUG



Debt Zmiana Data
Acadia Pharmaceuticals USD 0 0 2024-12
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amgen USD 60.1B 299M 2024-12
Arrowhead Research USD 409.41M 16.23M 2024-12
BioMarin Pharmaceutical USD 596.24M 1.61M 2024-12
Incyte USD 37.12M 840K 2025-03
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
Moderna USD 745M 683M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 31.26B 828M 2024-12
PTC Therapeutics USD 2.39B 389K 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Sanofi 17.91B 5.85B 2024-12
Sarepta Therapeutics USD 1.14B 90.44M 2024-12
Takeda JPY 4.84T 211.04B 2024-12
Tectonic Therapeutic USD 876K 115K 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Xencor USD 163.61M 145.69M 2024-12



Alnylam Pharmaceuticals DŁUG - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.